AUTL vs JCI · rev $71.9M vs P/E 44, rev $23.60B
Autolus Therapeutics Ltd (AUTL) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
AUTL currently screens at market cap $614.8M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the AUTL and JCI stock pages for the full models.
Not investment advice.